Shares of Resource Base (ASX:RBX) experienced a substantial increase of up to 21.4%, reaching A$0.170, the highest level seen since the end of August.

The significant increase came after the mineral exploration company announced an abundant number of outcropping pegmatites at its projects in Quebec, Canada, named Wali and Ernst Lake.

Indications suggest that these pegmatites may contain lithium.

The company’s stock has experienced an upwards trend overall, with an increase of 64.7% year to date as of the most recent market closure.

Resource Base (ASX:RBX) is a mineral exploration company primarily engaged in lithium discovery and extraction projects.

Shares in True North Copper (ASX:TNC) have seen an increase of as much as 5.4%, touching A$0.195, the highest since September 14.

The critical minerals explorer company has confirmed large-scale and high-grade copper-cobalt-silver mineralisation at its Mt Oxide Project, based in Queensland.

According to the company, the drilling results indicate a rapidly increasing grade and width of mineralisation.

The company’s stock has been on an upward trend, with an approximate 54% increase year to date, from the last close.

True North Copper is a company that focuses on exploration of critical minerals with ongoing projects located in Queensland.

Shares of Magnetic Resources are up 2.5% at A$0.82, potentially setting the scene for the best trading day since August 23, provided the gains hold.

The mineral exploration company announced that it has received binding commitments for a placement to raise A$4.8 million ($3.10 million).

The company has stated that the funds from this placement will be used to advance project development and increase the resource at its Laverton gold projects.

Despite this positive news, the stock is down approximately 7% year to date as of the last close.

Magnetic Resources is a mineral exploration company focused on the advancement and development of its Laverton Gold Projects.

BPH Global shares surged today, as much as 50% to A$0.003, positioning for the best day since Aug 11, given the gains sustain.

The biotech company announced it would fully acquire Foshan Gedishi Biotechnology, an operator of the birds' nest pilot study in partnership with BPH’s associates in China.

This deal is anticipated to resurrect and expand BPH’s bird nest enterprise in China, with the transaction expected to close by Oct 31.

The company’s stock has reached its apex level since Aug 15, despite a descent of 84.8% YTD.

BPH Global (ASX:BP8) is a biotechnology company that aims to develop and enhance the scope of their birds' nest business in China.

QX Resources (ASX:QXR) shares have witnessed a surge of as much as 16.7% to A$0.028 - reaching their peak since September 5.

The company, a specialty miner, announced that highly promising nickel-copper ores have been discovered at their offshore mine located in Sweden.

There has been a significant exchange of over 3.9 million shares, notably exceeding the 30-day average volume of 784,342 shares.

Despite last recorded up by 4.2%, the company has managed to curtail YTD losses to 40.5% from 42.9% at last closure.

QX Resources (ASX:QXR) is a specialty miner focusing on nickel and copper ores.

Shares of Blue Energy (ASX:BLU) suffered a significant drop, plummeting as much as 15.8% to A$0.016, marking its worst performance since late September of the previous year.

The energy firm reports that the Queensland Department of Resources rejected granting nine potential commercial area licenses within the Galilee Basin.

The department explains its decision, citing that petroleum production within the Galilee Basin area is unlikely to become commercially feasible in the following 15 years.

A surge in trading activity was also recorded, with approximately 2.7 million shares exchanged in contrast to a 30-day average trading volume of 988,812 shares.

As of the latest market close, the shares of Blue Energy (ASX:BLU) have tumbled by 65.5% for the year-to-date.

Blue Energy is an energy company based in Australia that’s mainly involved in the exploration, evaluation and development of coal seam and conventional gas resources.

Transurban Group (ASX:TCL) just shared an update about their CEO transition.

Michelle Jablko will step into her new role as Chief Executive Officer and Managing Director starting from October 19.

The current CEO, Scott Charlton, will continue his role until November 30 before leaving the company.

By the end of November 2023, Charlton will step down as the Chief Executive Officer.

Transurban Group is an infrastructure company specializing in toll road ownership and management.

Shares of Alderan Resources (ASX:AL8) increased by as much as 75% to A$0.014, potentially marking their best day since June 3, 2020, if the gains hold.

The gold mining company has announced that it is set to acquire seven lithium exploration projects in Brazil.

These projects comprise 24 granted exploration licenses that cover a vast area of 472 square kilometers within Brazil’s Eastern Lithium Belt.

The company’s stock achieved its highest level since July 11, 2022.

Roughly 28.8 million shares were exchanged, a significant surge compared to the 30-day average volume of 622,136.

The company’s stock has seen an uptick of 14.3% YTD, calculated till its last closing.

Alderan Resources (ASX:AL8) is a renowned gold mining company that now ventures into lithium exploration projects in Brazil.

Shares in medical equipment manufacturer Micro-X (ASX:MX1) have experienced a surge as high as 8.7% to A$0.125, a record level not seen since August 31.

This substantial increase is largely driven by the company’s announcement of receiving a A$1.5 million purchase order from the Australian government.

The order, comprising of Micro-X Rover systems, is set to be delivered in the early part of October.

An increased trading volume of approximately 609,500 shares was observed, double its average 30-day volume of 282,152 shares.

Despite the current surge, Micro-X’s stock is still down by 11.5% this year, as of the last close.

Micro-X is a manufacturer of innovative medical equipment.

Carly Holdings (ASX:CL8) announced that its annualised revenue run rate in August 2023 reached A$3.0 million.

The company also registered an impressive increase in average subscription revenue during July and August 2023, which showed a 100% rise compared to its September quarter in 2022.

Carly Holdings (ASX:CL8) is a business entity involved in various industries including holdings, investments, and global commerce.